These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10469931)

  • 1. Application of co-grinding to formulate a model pMDI suspension.
    Williams RO; Repka MA; Barron MK
    Eur J Pharm Biopharm; 1999 Sep; 48(2):131-40. PubMed ID: 10469931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of micronization method on the performance of a suspension triamcinolone acetonide pressurized metered-dose inhaler formulation.
    Williams RO; Brown J; Liu J
    Pharm Dev Technol; 1999 May; 4(2):167-79. PubMed ID: 10231878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of some commercially available spacer devices for the delivery of glucocorticoid steroids from a pMDI.
    Williams RO; Patel AM; Barron MK; Rogers TL
    Drug Dev Ind Pharm; 2001 May; 27(5):401-12. PubMed ID: 11448047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition and pharmacokinetics of an HFA formulation of triamcinolone acetonide delivered by pressurized metered dose inhaler.
    Hirst PH; Pitcairn GR; Richards JC; Rohatagi S; Gillen MS; Newman SP
    J Aerosol Med; 2001; 14(2):155-65. PubMed ID: 11681648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning aerosol particle size distribution of metered dose inhalers using cosolvents and surfactants.
    Saleem IY; Smyth HD
    Biomed Res Int; 2013; 2013():574310. PubMed ID: 23984381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol characterization of nebulized intranasal glucocorticoid formulations.
    Berlinski A; Waldrep JC
    J Aerosol Med; 2001; 14(2):237-44. PubMed ID: 11681655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
    Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
    Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of metering chamber volume and water level on the emitted dose of a suspension-based pMDI containing propellant 134a.
    Williams RO; Liu J; Koleng JJ
    Pharm Res; 1997 Apr; 14(4):438-43. PubMed ID: 9144728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel simvastatin inhalation formulation and characterisation.
    Tulbah AS; Ong HX; Colombo P; Young PM; Traini D
    AAPS PharmSciTech; 2014 Aug; 15(4):956-62. PubMed ID: 24806822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of a protein with propellant HFA 134a for aerosol delivery.
    Williams RO; Liu J
    Eur J Pharm Sci; 1999 Jan; 7(2):137-44. PubMed ID: 9845798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moisture uptake and its influence on pressurized metered-dose inhalers.
    Williams RO; Hu C
    Pharm Dev Technol; 2000; 5(2):153-62. PubMed ID: 10810745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
    Sheth P; Stein SW; Myrdal PB
    Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of glucocorticoids by jet nebulization: aerosol characteristics and output.
    Leflein J; Brown E; Hill M; Kelly HW; Loffert DT; Nelson HS; Szefler SJ
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):944-9. PubMed ID: 7751514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary peptide delivery: effect of taste-masking excipients on leuprolide suspension metered-dose inhalers.
    Zheng JY; Fulu MY; Lee DY; Barber TE; Adjei AL
    Pharm Dev Technol; 2001 Nov; 6(4):521-30. PubMed ID: 11775953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pMDI formulations for pulmonary delivery of proteins.
    Li HY; Seville PC
    Int J Pharm; 2010 Jan; 385(1-2):73-8. PubMed ID: 19854252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse aqueous microemulsions in hydrofluoroalkane propellants and their aerosol characteristics.
    Selvam P; Bharatwaj B; Porcar L; da Rocha SR
    Int J Pharm; 2012 Jan; 422(1-2):428-35. PubMed ID: 22044539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
    Jacobson K; Chervinsky P; Noonan M; Kane RE; Banerji D; Uryniak T
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control over hygroscopic growth of saline aqueous aerosol using Pluronic polymer additives.
    Haddrell AE; Hargreaves G; Davies JF; Reid JP
    Int J Pharm; 2013 Feb; 443(1-2):183-92. PubMed ID: 23333755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of water on the solubility of two steroid drugs in hydrofluoroalkane (HFA) propellants.
    Williams RO; Hu C
    Drug Dev Ind Pharm; 2001 Jan; 27(1):71-9. PubMed ID: 11247538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.